Paul G. Catrou

1.4k total citations · 1 hit paper
28 papers, 1.0k citations indexed

About

Paul G. Catrou is a scholar working on Surgery, Transplantation and Physiology. According to data from OpenAlex, Paul G. Catrou has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Transplantation and 7 papers in Physiology. Recurrent topics in Paul G. Catrou's work include Renal Transplantation Outcomes and Treatments (8 papers), Clinical Laboratory Practices and Quality Control (6 papers) and Renal Diseases and Glomerulopathies (5 papers). Paul G. Catrou is often cited by papers focused on Renal Transplantation Outcomes and Treatments (8 papers), Clinical Laboratory Practices and Quality Control (6 papers) and Renal Diseases and Glomerulopathies (5 papers). Paul G. Catrou collaborates with scholars based in United States. Paul G. Catrou's co-authors include Kimberly P. Briley, Carl E. Haisch, Lorita M. Rebellato, Steven C. Kazmierczak, Paul I. Terasaki, William T. Kendrick, Robert C. Harland, Paul Bolin, Junchao Cai and Scott A. Kendrick and has published in prestigious journals such as Journal of Clinical Investigation, Analytical Chemistry and Clinical Chemistry.

In The Last Decade

Paul G. Catrou

27 papers receiving 1000 citations

Hit Papers

Incidence and Impact of De Novo Donor-Specific Alloantibo... 2013 2026 2017 2021 2013 50 100 150 200 250

Peers

Paul G. Catrou
Luc De Pauw Belgium
T. Wujciak Germany
Scott A. Kendrick United States
B. Kiberd Canada
D. E. R. Sutherland United States
Martin F. Mozes United States
P. R. Rajagopalan United States
Paul G. Catrou
Citations per year, relative to Paul G. Catrou Paul G. Catrou (= 1×) peers E. Bertoni

Countries citing papers authored by Paul G. Catrou

Since Specialization
Citations

This map shows the geographic impact of Paul G. Catrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul G. Catrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul G. Catrou more than expected).

Fields of papers citing papers by Paul G. Catrou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul G. Catrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul G. Catrou. The network helps show where Paul G. Catrou may publish in the future.

Co-authorship network of co-authors of Paul G. Catrou

This figure shows the co-authorship network connecting the top 25 collaborators of Paul G. Catrou. A scholar is included among the top collaborators of Paul G. Catrou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul G. Catrou. Paul G. Catrou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rebellato, Lorita M., Junchao Cai, Kimberly P. Briley, et al.. (2013). Higher Risk of Kidney Graft Failure in the Presence of Anti-Angiotensin II Type-1 Receptor Antibodies. American Journal of Transplantation. 13(10). 2577–2589. 167 indexed citations
2.
Everly, Matthew J., Lorita M. Rebellato, Carl E. Haisch, et al.. (2013). Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts. Transplantation. 95(3). 410–417. 292 indexed citations breakdown →
3.
Rebellato, Lorita M., Carl E. Haisch, Miyuki Ozawa, et al.. (2011). A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients.. PubMed. 337–40. 9 indexed citations
4.
Everly, Matthew J., Lorita M. Rebellato, Mikki Ozawa, et al.. (2010). Beyond Histology: Lowering Human Leukocyte Antigen Antibody to Improve Renal Allograft Survival in Acute Rejection. Transplantation. 89(8). 962–967. 47 indexed citations
5.
Cook, Paul, et al.. (2008). Effect of a Program to Reduce Hospital Ciprofloxacin Use on Nosocomial Pseudomonas aeruginosa Susceptibility to Quinolones and Other Antimicrobial Agents. Infection Control and Hospital Epidemiology. 29(8). 716–722. 15 indexed citations
6.
Mao, Qiuxia, Junchao Cai, Kimberly P. Briley, et al.. (2007). Extremely High Association Between Appearance of HLA Antibodies and Failure of Kidney Grafts in a Five-Year Longitudinal Study. American Journal of Transplantation. 7(4). 864–871. 175 indexed citations
7.
Cook, Paul, Paul G. Catrou, Michael D. Gooch, & D. Holbert. (2006). Effect of reduction in ciprofloxacin use on prevalence of meticillin-resistant Staphylococcus aureus rates within individual units of a tertiary care hospital. Journal of Hospital Infection. 64(4). 348–351. 33 indexed citations
8.
Rebellato, Lorita M., Miyuki Ozawa, Kathryn M. Verbanac, et al.. (2006). Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.. PubMed. 241–53. 16 indexed citations
9.
Kazmierczak, Steven C., Alex Robertson, Paul G. Catrou, et al.. (2002). Direct Spectrophotometric Method for Measurement of Bilirubin in Newborns: Comparison with HPLC and an Automated Diazo Method. Clinical Chemistry. 48(7). 1096–1097. 60 indexed citations
10.
Kazmierczak, Steven C., Paul G. Catrou, & Kimberly P. Briley. (2000). Transient Nature of Interference Effects from Heterophile Antibodies: Examples of Interference with Cardiac Marker Measurements. Clinical Chemistry and Laboratory Medicine (CCLM). 38(1). 33–39. 27 indexed citations
11.
Kazmierczak, Steven C., et al.. (1999). Multiple Regression Analysis of Interference Effects from a Hemoglobin-Based Oxygen Carrier Solution. Clinical Chemistry and Laboratory Medicine (CCLM). 37(4). 453–464. 12 indexed citations
12.
Catrou, Paul G. & Kenneth Emancipator. (1998). The Authors' Replies. American Journal of Clinical Pathology. 109(4). 497–498. 1 indexed citations
13.
Kazmierczak, Steven C., Paul G. Catrou, & Donald A. Boudreau. (1998). Simplified interpretative format for assessing test interference: studies with hemoglobin-based oxygen carrier solutions. Clinical Chemistry. 44(11). 2347–2352. 7 indexed citations
14.
Kazmierczak, Steven C. & Paul G. Catrou. (1995). Clinical informatics. Analytical Chemistry. 67(12). 437–441. 8 indexed citations
15.
Kazmierczak, Steven C., Paul G. Catrou, & F Van Lente. (1993). Diagnostic accuracy of pancreatic enzymes evaluated by use of multivariate data analysis. Clinical Chemistry. 39(9). 1960–1965. 29 indexed citations
16.
Catrou, Paul G.. (1992). Laboratory Medicine: Test Selection and Interpretation. American Journal of Clinical Pathology. 98(6). 648–648. 9 indexed citations
17.
Yang, Yih‐Ming, Allan J. Rosenberg, Paul G. Catrou, et al.. (1985). Cobalamin malabsorption in three siblings due to an abnormal intrinsic factor that is markedly susceptible to acid and proteolysis.. Journal of Clinical Investigation. 76(6). 2057–2065. 31 indexed citations
18.
Lum, Gifford, et al.. (1983). Clinical Assessment of the Electrophoretic Separation of Alkaline Phosphatase Isoenzymes. American Journal of Clinical Pathology. 80(5). 682–685. 5 indexed citations
19.
Boudreau, Donald A., et al.. (1981). Ranking Diagnostic Protocols—a Proposed Process Based on Use of the Nine-cell Diagnostic Decision Matrix. American Journal of Clinical Pathology. 76(2). 127–132. 2 indexed citations
20.
Beeler, Myrton F., et al.. (1980). Reasonableness of Use of the Serum Isoenzymes Creatine Kinase and Lactate Dehydrogenase for the Diagnosis of Myocardial Infarction at a Medical Center. American Journal of Clinical Pathology. 74(2). 202–204. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026